Ovarian Cancer Competition Accelerates With Clovis Drug Data

BloombergOvarian Cancer Competition Accelerates With Clovis Drug DataBloombergClovis Oncology Inc.'s experimental drug shrunk tumors in 82 percent of women with a certain type of deadly ovarian cancer, results that offer new promise for patients and promise to heat up the rivaly between the small Colorado biotech and U.K. drug ...and more »

Share this post